Adult-onset Still's disease: An uncommon differential diagnosis of urticaria and treatment with anakinra

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 1, 2009, Pages 104-106

  Gesierich, A ^a   Stoevesandt, J ^a   Kneitz, C ^a   Brocker E B ^a   Schon M P ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; DIMETINDENE; IBUPROFEN; METHOTREXATE; PANTOPRAZOLE; PREDNISOLONE; RANITIDINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ADULT ONSET STILL DISEASE; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT OUTCOME; URTICARIA;

EID: 57649230164     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.2746.x     Document Type: Letter

References (10)

1. Bywaters EGL. Still's disease in the adult. Ann Rheum Dis 1971 30 : 121 133.
2. Yamaguchi M, Ohta A, Tsunematsu T et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992 19 : 424 430.
3. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005 201 : 1355 1359.
4. Mert A, Ozaras R, Tabak F et al. Fever of unknown origin: a review of 20 patients with adult-onset Still's disease. Clin Rheumatol 2003 22 : 89 93.
5. Salaffi F, Filosa G, Bugatti L, Maestrini MD. Urticaria as a presenting manifestation of adult-onset Still's disease. Clin Rheumatol 2000 19 : 389 391.
6. Setterfield JF, Hughes GR, Kobza Black A. Urticaria as a presentation of adult Still's disease. Br J Dermatol 1998 138 : 906 908.
7. Soy M. A case of adult-onset Still's disease presenting with angioedema. Clin Rheumatol 2004 23 : 92.
8. Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 2006 36 : 144 152.
9. Furst DE. Anakinra: review of recombinant human interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 2004 26 : 1960 1975.
10. Furst DE, Breedveld F, kalden J et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. Ann Rheum Dis 2006 65 : 2 15.